Cargando…
CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in in vitro and in vivo models of Parkinson’s disease
Mitochondrial dysfunction is a significant pathological alteration that occurs in Parkinson’s disease (PD), and the Thr61Ile (T61I) mutation in coiled-coil helix coiled-coil helix domain containing 2 (CHCHD2), a crucial mitochondrial protein, has been reported to cause Parkinson’s disease. F1F0-ATPa...
Autores principales: | Chen, Xiang, Lin, Yuwan, Zhang, Zhiling, Tang, Yuting, Ye, Panghai, Dai, Wei, Zhang, Wenlong, Liu, Hanqun, Peng, Guoyou, Huang, Shuxuan, Qiu, Jiewen, Guo, Wenyuan, Zhu, Xiaoqin, Wu, Zhuohua, Kuang, Yaoyun, Xu, Pingyi, Zhou, Miaomiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479855/ https://www.ncbi.nlm.nih.gov/pubmed/37488867 http://dx.doi.org/10.4103/1673-5374.378010 |
Ejemplares similares
-
Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease
por: Mo, Mingshu, et al.
Publicado: (2021) -
Association of LAG3 genetic variation with an increased risk of PD in Chinese female population
por: Guo, Wenyuan, et al.
Publicado: (2019) -
CHCHD2 p.Thr61Ile knock‐in mice exhibit motor defects and neuropathological features of Parkinson's disease
por: Fan, Liyuan, et al.
Publicado: (2022) -
CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease
por: Lu, Lin, et al.
Publicado: (2022) -
Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease
por: Lin, Yuwan, et al.
Publicado: (2021)